Counterpart Health appoints Vicky Bruner as VP of Operations to enhance growth and service delivery in healthcare.
Quiver AI Summary
Counterpart Health, Inc., a subsidiary of Clover Health Investments, has announced the appointment of Vicky Bruner as Vice President of Operations as the company seeks to meet increasing demand from payors and providers. Bruner will oversee key operational areas such as customer implementations and provider engagement, ensuring consistency as Counterpart grows and engages in more complex partnerships. CEO Conrad Wai highlighted Bruner's extensive experience in provider enablement and healthcare systems as crucial for the company's expansion. Prior to joining Counterpart, Bruner was Vice President of Network Performance at Optum Care Network, where she improved quality performance across multiple health plans. She expressed enthusiasm for being part of a team that leverages AI to enhance clinical operations and patient outcomes. Counterpart Health aims to extend its AI-powered services beyond Medicare Advantage plans to improve healthcare costs and outcomes nationwide.
Potential Positives
- Appointment of Vicky Bruner as Vice President of Operations strengthens leadership as Counterpart scales to meet increasing demand.
- Bruner's extensive experience in healthcare operations and provider engagement positions Counterpart for successful growth and complex partnerships.
- Counterpart Assistant's unique approach enhances patient outcomes and reduces clinician workload, highlighting the value of the AI-powered platform.
Potential Negatives
- Counterpart's press release does not provide specific metrics or quantitative performance indicators to substantiate claims of growth or effectiveness, which may raise concerns about transparency and accountability.
- The appointment of a new Vice President of Operations could imply prior operational challenges or inefficiencies that necessitated a leadership change, potentially signaling existing problems within the company.
- The focus on scaling to meet growing demand suggests that the company may currently be struggling to keep up with operational pressures, indicating potential instability or growing pains in its expansion efforts.
FAQ
Who has been appointed as Vice President of Operations at Counterpart Health?
Vicky Bruner has been appointed as the Vice President of Operations at Counterpart Health.
What are the main responsibilities of Vicky Bruner at Counterpart?
Vicky Bruner will lead customer implementations, provider network engagement, clinician onboarding, and longitudinal account support.
How does Counterpart Health use AI in healthcare?
Counterpart Health uses AI to enhance physician enablement, reduce administrative tasks, and improve patient outcomes in primary care.
What is the purpose of Counterpart Assistant?
Counterpart Assistant provides clinical insights and supports primary care providers in delivering value-based care and improving healthcare outcomes.
What experience does Vicky Bruner bring to her new role?
Bruner brings extensive experience in provider enablement, healthcare systems, and optimizing operations in risk management across Medicare and Medicaid.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$CLOV Insider Trading Activity
$CLOV insiders have traded $CLOV stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $CLOV stock by insiders over the last 6 months:
- CARLADENISE ARMBRISTER EDWARDS sold 200,000 shares for an estimated $722,000
- CONRAD WAI (CEO, Counterpart Health) has made 0 purchases and 2 sales selling 209,797 shares for an estimated $692,968.
- BRADY PATRICK PRIEST (CEO of Home Care) sold 75,000 shares for an estimated $276,000
- KAREN SOARES (General Counsel & Secretary) sold 52,500 shares for an estimated $199,500
- JAMIE L. REYNOSO (CEO, Medicare Advantage) has made 0 purchases and 3 sales selling 42,251 shares for an estimated $115,276.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CLOV Hedge Fund Activity
We have seen 96 institutional investors add shares of $CLOV stock to their portfolio, and 88 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC added 4,558,305 shares (+365.9%) to their portfolio in Q1 2025, for an estimated $16,364,314
- VANGUARD GROUP INC added 994,904 shares (+5.1%) to their portfolio in Q1 2025, for an estimated $3,571,705
- BANK OF AMERICA CORP /DE/ added 979,733 shares (+344.7%) to their portfolio in Q1 2025, for an estimated $3,517,241
- CITADEL ADVISORS LLC added 822,712 shares (+90.3%) to their portfolio in Q1 2025, for an estimated $2,953,536
- 8 KNOTS MANAGEMENT, LLC added 817,905 shares (+inf%) to their portfolio in Q1 2025, for an estimated $2,936,278
- MARSHALL WACE, LLP added 805,762 shares (+21.4%) to their portfolio in Q1 2025, for an estimated $2,892,685
- JANE STREET GROUP, LLC added 796,014 shares (+149.6%) to their portfolio in Q1 2025, for an estimated $2,857,690
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CLOV Analyst Ratings
Wall Street analysts have issued reports on $CLOV in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Canaccord Genuity issued a "Buy" rating on 03/03/2025
To track analyst ratings and price targets for $CLOV, check out Quiver Quantitative's $CLOV forecast page.
Full Release
WILMINGTON, Del., July 29, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI-powered physician-enablement platform, today announced the appointment of Vicky Bruner as Vice President of Operations.
As Counterpart scales to meet growing demand from payors and providers nationwide, Bruner will lead several critical functions including customer implementations, provider network engagement, clinician onboarding and training, and longitudinal account support. Her work will be foundational, ensuring operational readiness and delivery consistency as Counterpart expands its growth initiatives and takes on increasingly complex partnerships.
“Vicky is a process-driven operator with a deep understanding of provider enablement, healthcare systems, and value-based care models,” said Conrad Wai, CEO of Counterpart. “Her experience building and optimizing systems for efficient service delivery, spearheading provider engagement with new products and services, and driving business outcomes will be invaluable as we continue to expand Counterpart’s footprint.”
Bruner most recently served as Vice President of Network Performance at Optum Care Network, where she led risk operations across five health plans in Washington and Oregon and drove improvements in quality performance and cost across Medicare and Medicaid populations. Her experience driving P&L performance across multiple government programs, in both payor and provider settings, while driving aligned execution at scale, position her well for Counterpart’s next phase of growth.
“Counterpart Assistant brings clinical insights to primary care providers at the point of care in a manner unlike any other value-based care program or population health solution,” said Bruner. “I am proud to be a part of the team that is dedicated to using AI, clinical data and interoperability in a new way that reduces administrative work for clinicians and provides real results for patients.”
About Counterpart Health
Counterpart Health
, a subsidiary of Clover Health Investments, Corp., or Clover Health, is a leading AI powered physician enablement platform. Counterpart Health’s flagship software platform, Counterpart Assistant, was incubated by Clover Health as Clover Assistant and has helped improve plan performance and clinical outcomes for Medicare members through proprietary AI technology. Counterpart Health extends the benefits of the data-driven technology platform outside of Clover Health’s Medicare Advantage plan to a wider audience, to enable enhanced patient outcomes and reduced healthcare costs nationwide. Clover Health has published data demonstrating the technology’s impact on
Medication Adherence
and
Congestive Heart Failure
, as well as the earlier identification and management of
Diabetes
and
Chronic Kidney Disease
.
Investor Relations:
Ryan Schmidt
[email protected]
Press Inquiries:
[email protected]